Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corporation Reports Second Quarter
February 6, 2017 4:15 PM ESTTEANECK, N.J., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2016.
Highlights for the December 2016 quarter (compared to the December 2015 quarter)
Net sales of $192 million, equal to the prior yearNet income of $13 million, a decrease of $16.8 million, or 56%Diluted EPS of $0.34, a decrease of $0.41, or 56%Adjusted EBITDA of $31 million, an increase of $3 million, or 10%Adjusted diluted EPS of $0.39, an increase of $0.02, or 5%ÂCOMMENTARY
We are very... More
